Stem Cell Pool Restoration via Epigenetic Resetting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for reversing biological aging focus on extending telomeres or removing senescent cells, but these approaches either allow cells to continue aging epigenetically or have temporary health benefits, failing to address the root cause of aging, which is damage to the epigenetic code and decline in stem cell pools.
Innovation Solution
The method involves using mitochondrial switches to promote stem cell self-renewal, remove aberrant epigenetic marks, and restore ATP production by administering therapeutically effective doses of stearic acid, sulforaphane, and fullerene derivatives, along with demethylase and biogenesis promoters, to expand stem cell pools and reduce epigenetic age.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If telomeres are extended with supplements such as astragalus extracts containing cycloastragenol, then the Hayflick crisis is delayed and short-term health benefits are provided, but cells continue to age epigenetically and become ever more dysfunctional
Solution Approach 1:
The patent removes senescent cells from the organism through selective elimination, extracting the harmful accumulated dysfunctional cells that cause inflammation and drive aging. This is achieved through senolytic compounds that specifically target and eliminate senescent cells, thereby preventing the accumulation of epigenetic damage while maintaining healthy cell populations.
Solution Approach 2:
The patent changes the epigenetic parameters of cells by removing aberrant methylation marks and restoring proper epigenetic programming. This involves using demethylating agents and epigenetic modulators to reset the epigenetic clock, thereby reversing the epigenetic aging process and restoring cellular functionality without merely extending telomere length.
2Reliability
If senescent cells are removed naturally by apoptosis, then cell turnover is maintained, but with age the number of cells reaching senescence steadily increases while stem cell pools decline and clearance and replacement fail to keep up
Solution Approach 1:
The patent activates the organism's own stem cell regenerative capacity through endogenous stem cell stimulation. By using compounds that naturally promote stem cell proliferation and differentiation, the body's own repair mechanisms are enhanced to clear senescent cells and replace them with youthful stem cell-derived cells, creating a self-sustaining regenerative cycle.
Solution Approach 2:
The patent applies senolytic treatment at specific intervals to prevent the accumulation of senescent cells before they can cause significant damage. By proactively eliminating senescent cells before they accumulate to harmful levels, the system maintains cellular health and prevents the vicious cycle of aging from establishing itself.
3Reliability
If epigenetic marks are removed and stem cell pools are expanded, then epigenetic age is reduced and youthful function is restored, but the process requires multiple therapeutic agents and prolonged treatment
Solution Approach 1:
The patent combines multiple therapeutic agents into a single polypharmacological formulation that simultaneously targets multiple aging pathways. By merging senolytic compounds, epigenetic modulators, and stem cell proliferants into one integrated treatment, the patent simplifies the administration process while maintaining the comprehensive effects of addressing telomere maintenance, epigenetic resetting, and senescent cell clearance concurrently.
Data Source
AI summary
Disclosed are methods and compositions for reducing the epigenetic age of organisms, especially that of adult humans, which provide for proliferating endogenous stem cells, removing aberrant epigenetic marks from chromosomes and mitochondrial DNA, and replacement of senescent cells.